By Amin H. Karim MD
An article published in the Texas Heart Institute Journal in 1988 after the TIMI Trial 1 had been completed and the standard of care for acute myocardial infarction was thrombolysis with Tissue Plasminogen Activator. (TPA) made by Genentec. We wrote this article as fellows of the Baylor College of Medicine, Houston, Texas. (AHK November 24 2023)
GlobeMedic 